TRIUMF and CNIC to work together to help further realize the benefits that medical isotopes bring in diagnosing and treating life-threatening illnesses, from cancer to dementia to cardiac disease.
First competition of newly launched program provides funding support for projects spearheaded by early career Canadian researchers – including several members of the TRIUMF community
In his eighth year of teaching, and after three nominations, Dr. Marcello Pavan has been awarded the Killam Teaching Prize for his outstanding teaching as part of the Faculty of Science at the University of British Columbia.
Dr. Graeme Luke has been awarded the 2019 CAP/DCMMP Brockhouse Medal for his contributions in the field of superconductor research using muon-spin techniques and his leading role in developing these techniques at TRIUMF.
The Institute is expected to begin operations in late 2020 and will be a state-of-the-art facility for the research and production of next-generation, life-saving medical isotopes and radiopharmaceuticals
Speaking at the 11th International Symposium on Targeted Alpha Therapy (TAT 11) in Ottawa, the organizations announced today a new partnership that brings together their respective R&D, manufacturing, and commercialization strengths to develop innovative, personalized cancer treatments.
